NDC 33261-019-10 - CELEBREX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 33261-019
- Requested NDC
- 33261-019-10
- Package NDCs from labels
- 33261-019-10, 33261-019-34, 33261-019-30, 33261-019-60
- Manufacturer
- Aidarex Pharmaceuticals LLC
- Effective date
- 2012-09-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CELEBREX - Aidarex Pharmaceuticals LLC | Aidarex Pharmaceuticals LLC | 2012-09-12 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 33261-019-10 | CELEBREX | 10 in 1 BOTTLE, PLASTIC | CAPSULE | 10 | 1 | |
| 33261-019-30 | CELEBREX | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | 1 | |
| 33261-019-34 | CELEBREX | 10 in 1 CARTON | CAPSULE | 10 | 1 | |
| 33261-019-60 | CELEBREX | 60 in 1 BOTTLE, PLASTIC | CAPSULE | 60 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 33261-019-10 | EA - Each | 33261-019 | 2d59dde0-26e3-486c-a6e0-14d42fb4bc5b | 1 | 2015-10-02 |
| 33261-019-30 | EA - Each | 33261-019 | 37d175b5-dd8d-4196-95f9-512e3419bf00 | 1 | 2015-10-02 |
| 33261-019-60 | EA - Each | 33261-019 | 8e8ccf32-0c3c-45df-b10f-4f9ef51c35ab | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CELECOXIB | ACTIVE INGREDIENT | JCX84Q7J1L | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| CELECOXIB | ACTIVE MOIETY | JCX84Q7J1L | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Celecoxib | CELECOXIB | Alembic Pharmaceuticals Limited | 14e8d788-e44c-4a40-8678-25cf45fed477 | 2025-09-18 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | FZ989GH94E |
| TRIMO SAN | OXYQUINOLINE SULFATE AND SODIUM LAURYL SULFATE | CooperSurgical, Inc. | 1e4a1caa-e6ba-44ef-8347-07e6385a7c9e | 2025-09-03 | Warnings | 368GB5141J |
| CELECOXIB | CELECOXIB | PHOENIX RX LLC | 3a669c28-fbc7-827c-e063-6394a90a0829 | 2025-08-03 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| VYSCOXA | CELECOXIB | Carwin Pharmaceutical Associates, LLC | 5094d47e-f791-4190-9397-b7500143a74d | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | PHOENIX RX LLC | 3a7b127e-c919-418f-e063-6394a90a06d0 | 2025-07-21 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Proficient Rx LP | 3a450db8-313c-4120-9b8e-58c956323fa4 | 2025-06-01 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | A-S Medication Solutions | 95b2ced1-eca2-4c25-aa10-c9fb86b353a3 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | A-S Medication Solutions | 7b8e923c-253f-461e-94d7-669e75dc73e9 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| celecoxib | CELECOXIB | Bryant Ranch Prepack | 351f5f07-bdd4-9893-e063-6394a90a7281 | 2025-05-14 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | Micro Labs Limited | 408b30d6-f5c2-4239-b993-d8f77a8e160b | 2025-05-13 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Asclemed USA, Inc. | 5d0dcac1-237c-47aa-bcfb-50fa20b5b838 | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | PD-Rx Pharmaceuticals, Inc. | 3191c9dc-bfdf-0591-e054-00144ff8d46c | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| celecoxib | CELECOXIB | RedPharm Drug, Inc. | 50c29846-3426-0310-e054-00144ff8d46c | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | Quallent Pharmaceuticals Health LLC | aaa3a4f5-b281-415f-a08c-e0cefdae2fb5 | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | Cipla USA Inc. | d12625b1-2af9-4532-af91-d40b65eeffef | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | NorthStar RxLLC | ce61a585-5ac0-4185-99eb-a9511cd25a98 | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| celecoxib | CELECOXIB | Bryant Ranch Prepack | ac5c0d72-1bb3-4065-b2f4-5516b0869775 | 2025-02-20 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | NCS HealthCare of KY, LLC dba Vangard Labs | 34bef49c-eca1-4f17-9b1b-55900ac40829 | 2025-02-20 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Walgreens Soothing Eye Relief Lubricant Eye Drops | POLYVINYL ALCOHOL, POVIDONE | Walgreens Co. | 29b7387b-ad65-3a11-e063-6394a90a6a15 | 2025-02-14 | Warnings | FZ989GH94E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.